AGRF Launches "Proteomics Pool Party" to Accelerate Multi-Omics Research

/
AGRF Launches "Proteomics Pool Party" to Accelerate Multi-Omics Research

Kickstart Your Proteomics Projects—No Big Sample Set? No Problem.

AGRF’s Proteomics Pool Party is here! Designed for early-stage researchers and pilot studies, this new initiative lets you pool small sample volumes and still access world-class proteomics analysis—powered by AGRF and Olink®.

With expert-backed workflows, simplified sample submission, and full support, it’s the perfect way to make a big impact with minimal input.

Bonus: Use promo code PROMO-PRO-190825 to enter our Pool Party Pack giveaway!

Read More

Celebrating our first Olink Reveal™ project

/
Celebrating our first Olink Reveal™ project

We’re excited to share the successful completion of our first client project using the Olink Reveal™ workflow—a cutting-edge, cost-effective platform for profiling ~1,000 proteins with PEA-NGS technology. Ideal for pilot studies, Olink Reveal supports biomarker discovery, target identification, and deeper insights into disease detection and treatment response.

Read More

AGRF Partners with Integrated Sciences to Offer Cutting-Edge Epigenetic Services with EpiCypher CUT&RUN and CUT&Tag Technologies→

/
AGRF Partners with Integrated Sciences to Offer Cutting-Edge Epigenetic Services with EpiCypher CUT&RUN and CUT&Tag Technologies

AGRF (Australian Genome Research Facility Ltd) and Integrated Sciences are excited to announce a new partnership that will bring advanced genomics capabilities to researchers across Australia and New Zealand. This collaboration will enable AGRF’s Advanced Genomics group to offer cutting-edge epigenetic services utilising EpiCypher’s CUT&RUN and CUT&Tag technologies.

Read More

AGRF Expands Olink® Platform with Signature Q100, Boosting Biomarker Discovery and Prognosis Capabilities

/
AGRF Expands Olink® Platform with Signature Q100, Boosting Biomarker Discovery and Prognosis Capabilities

Media Release

AGRF is thrilled to announce the expansion of its Olink® fleet with the addition of the Olink Signature Q100. Funded by The Kids Research Institute (The Kids) in Perth, the platform joins our certified Olink Explore HT and Explore 3072 workflows and will allow us to run the Olink Target 96 and 48 workflows, enabling researchers with both absolute and relative quantitative proteomic data, driving the identification and validation of biomarkers from early discovery to implementation and disease risk prediction.

Read More

Milestone Achievement For Paediatric Cancer Research

/
Milestone Achievement For Paediatric Cancer Research

In an exciting step forward for children’s cancer research, the Australian Cancer Research Foundation (ACRF) has awarded a $2 million grant to Children’s Cancer Institute.  The grant will advance the initiation of their Spatial Immune-oncology Research program, aiming to unlock the potential of immunotherapies specifically tailored for childhood cancer. A key partnership with AGRF will introduce our Olink technology for in-depth protein analysis, unlocking new possibilities in paediatric cancer research.

Read More

AGRF: Bringing Olink® Next Generation Proteomic Technology to Australia.

/
AGRF: Bringing Olink® Next Generation Proteomic Technology to Australia.

AGRF is thrilled to announce the introduction of the Olink Explore high throughput platform to our fleet of cutting-edge technologies, bringing the most advanced proteomic technology to Australia and positioning AGRF as a truly multi-omics destination. This strategic move promises to be a game changer in precision medicine, offering researchers a full multi-omics profile of patient and biobank samples.

Read More